BG Medicine Announces One-for-Four Reverse Stock Split
July 08, 2015 at 17:00 PM EDT
BG Medicine, Inc. (Nasdaq: BGMD), the developer of the BGM Galectin-3® Test, today announced the effectiveness of a one-for-four reverse ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.